tiprankstipranks
Advertisement
Advertisement

SEPN Stock Latest News

3 Best Tech Stocks to Buy this Week 04/15/26, According to Top Analysts
Market News3 Best Tech Stocks to Buy this Week 04/15/26, According to Top Analysts
9d ago
ALLT
CLBT
Septerna: Advancing GPCR Pipeline and Strategic Partnerships Support Buy Rating and $40 Price Target
PremiumRatings
Septerna: Advancing GPCR Pipeline and Strategic Partnerships Support Buy Rating and $40 Price Target
10d ago
SEPN
Septerna Begins Phase 1 Trial of Oral SEP-479
PremiumCompany Announcements
Septerna Begins Phase 1 Trial of Oral SEP-479
11d ago
8K
SEPN
Septerna doses first patients in SEP-479 trial
PremiumThe Fly
Septerna doses first patients in SEP-479 trial
11d ago
SEPN
Septerna price target raised to $38 from $34 at JPMorgan
PremiumThe Fly
Septerna price target raised to $38 from $34 at JPMorgan
1M ago
SEPN
Septerna, Inc. (SEPN) Q4 Earnings Cheat Sheet
PremiumPre-EarningsSepterna, Inc. (SEPN) Q4 Earnings Cheat Sheet
1M ago
SEPN
Septerna price target raised to $35 from $34 at Truist
Premium
The Fly
Septerna price target raised to $35 from $34 at Truist
1M ago
SEPN
Septerna files automatic mixed securities shelf
Premium
The Fly
Septerna files automatic mixed securities shelf
1M ago
SEPN
Septerna: Novo-Backed GPCR Platform and Best-in-Class Potential for Oral MRGPRX2 Inhibitor SEP-631 Support Buy Rating
PremiumRatings
Septerna: Novo-Backed GPCR Platform and Best-in-Class Potential for Oral MRGPRX2 Inhibitor SEP-631 Support Buy Rating
2M ago
SEPN
Septerna reports Q4 EPS (24c), consensus (22c)
PremiumThe Fly
Septerna reports Q4 EPS (24c), consensus (22c)
2M ago
SEPN
Septerna (SEPN): Early Proof-of-Concept for SEP-631 in Mast Cell–Driven Disease Supports Long-Term Growth Potential
PremiumRatings
Septerna (SEPN): Early Proof-of-Concept for SEP-631 in Mast Cell–Driven Disease Supports Long-Term Growth Potential
2M ago
SEPN
Septerna price target raised to $40 from $35 at H.C. Wainwright
PremiumThe Fly
Septerna price target raised to $40 from $35 at H.C. Wainwright
2M ago
SEPN
Septerna Advances SEP-631 After Positive Phase 1 Results
PremiumCompany AnnouncementsSepterna Advances SEP-631 After Positive Phase 1 Results
2M ago
8K
SEPN
Septerna announces results from Phase 1 trial of SEP-631
Premium
The Fly
Septerna announces results from Phase 1 trial of SEP-631
2M ago
SEPN
Septerna: Advancing GPCR Pipeline and De-Risked Valuation Support Upgraded Buy Rating and $35 Target
Premium
Ratings
Septerna: Advancing GPCR Pipeline and De-Risked Valuation Support Upgraded Buy Rating and $35 Target
3M ago
SEPN
Septerna price target raised to $35 from $30 at H.C. Wainwright
PremiumThe Fly
Septerna price target raised to $35 from $30 at H.C. Wainwright
3M ago
SEPN
Septerna to Present GPCR Pipeline Updates at JPM Conference
PremiumCompany Announcements
Septerna to Present GPCR Pipeline Updates at JPM Conference
3M ago
8K
SEPN
Septerna Appoints Mark Wilson as Chief Legal Officer
PremiumCompany Announcements
Septerna Appoints Mark Wilson as Chief Legal Officer
4M ago
8K
SEPN
Septerna appoints Mark Wilson as chief legal officer
PremiumThe Fly
Septerna appoints Mark Wilson as chief legal officer
4M ago
NKTR
SEPN
Coty downgraded, Spruce Biosciences initiated: Wall Street’s top analyst calls
PremiumThe FlyCoty downgraded, Spruce Biosciences initiated: Wall Street’s top analyst calls
4M ago
BC
AME
Septerna initiated with a Buy at JonesResearch
Premium
The Fly
Septerna initiated with a Buy at JonesResearch
4M ago
SEPN
Septerna initiated with a Strong Buy at Raymond James
Premium
The Fly
Septerna initiated with a Strong Buy at Raymond James
4M ago
SEPN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >